Therapeutic management of pyoderma gangrenosum

被引:40
作者
Ehling, A [1 ]
Karrer, S [1 ]
Klebl, F [1 ]
Schäffler, A [1 ]
Müller-Ladner, U [1 ]
机构
[1] Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 10期
关键词
D O I
10.1002/art.20559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to its complex and variable pathophysiology, the differential diagnosis and treatment of PG require intensive interdisciplinary cooperation, especially by rheumatologists, with specialists in dermatology and internal medicine. Only a few controlled studies have been performed; nevertheless, as a result of various novel developments, an array of therapeutic approaches exists that can be adapted to the specific problems of the individual patient. These recent approaches are also the basis for treatment recommendations to be validated in the future for managing this painful and sometimes debilitating disease.
引用
收藏
页码:3076 / 3084
页数:9
相关论文
共 83 条
[41]   PYODERMA GANGRENOSUM TREATED WITH CLOFAZIMINE - REPORT OF 3 CASES [J].
KARK, EC ;
DAVIS, BR ;
POMERANZ, JR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 4 (02) :152-159
[42]  
Khachemoune A, 2002, INTERNET J DERMATOL, V1, P2
[43]   Pyoderma gangrenosum in two siblings: A familial predisposition [J].
Khandpur, S ;
Mehta, S ;
Reddy, BSN .
PEDIATRIC DERMATOLOGY, 2001, 18 (04) :308-312
[44]   Use of a lyophilized bovine collagen matrix in postoperative wound healing [J].
Kolenik, SA ;
McGovern, TW ;
Lefell, DJ .
DERMATOLOGIC SURGERY, 1999, 25 (04) :303-306
[45]  
Kuner N, 2000, HAUTARZT, V51, P519, DOI 10.1007/s001050051167
[46]  
LACY CF, 2004, DRUG INFORMATION HDB, P1208
[47]  
LACY CF, 2004, LEXI COMP, P341
[48]  
LACY CF, 2004, DRUG INFORMATION HDB, P294
[49]  
LACY CF, 2004, DRUG INFORMATION HDB, P1148
[50]  
LACY CF, 2004, DRUG INFORMATION HDB, P148